August 2, 2023
Authored and Edited by Dan F. Klodowski; Umber Aggarwal; Deena Kablaoui Lanier; Elliot C. Cook; Aaron L. Parker
In June, the PTAB cancelled 366 (71.76%) instituted claims across 36 IPR and PGR Final Written Decisions, including decisions issued following remand from the Federal Circuit. After review, 107 (20.98%) instituted claims survived, and patent owners conceded 37 (7.25%) instituted claims through motions to amend or disclaimer. For comparison, the cumulative average cancellation rate of instituted claims in IPR, CBM, and PGR Final Written Decisions is about 72%.
On a per-case basis, no instituted or substitute claims survived in 21 (58.33%) decisions, all instituted claims survived in 7 (19.44%) decisions, and a mixed outcome occurred in 8 (22.22%) decisions. A mixed outcome occurs where at least one instituted or substitute claim remains patentable, and at least one is cancelled, in a Final Written Decision.
Through June 30, 2023, the PTAB has cumulatively granted 603 (15.82%) proposed substitute claims in motions to amend while denying 3,208 (84.18%) proposed substitute claims in IPRs.
The overall cumulative instituted claim survival rate in IPRs, CBMs, and PGRs through June 30, 2023, broken down by technology center, is as follows:
The cumulative number of Final Written Decisions through June 30, 2023, separated by technology center, is as follows:
Additional cumulative statistics on the Board’s IPR, CBM, and PGR decisions, updated through June 30, 2023, are available here on the At the PTAB blog.
Copyright © 2023 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.